Description
LXH254 is a type II RAF inhibitor.
| Product Unit Size | Cost | Quantity | Stock |
|---|
LXH254 is a type II RAF inhibitor.
| Cas No. | 1800398-38-2 |
|---|---|
| Purity | ≥99% |
| Formula | C25H25F3N4O4 |
| Formula Wt. | 502.49 |
| IUPAC Name | N-[3-[2-(2-hydroxyethoxy)-6-morpholin-4-ylpyridin-4-yl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide |
| Synonym | Naporafenib |
| Appearance | White powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Monaco K, Delach S, Yuan J, et al. LXH254, a potent and selective ARAF-sparing inhibitor of BRAF and CRAF for the treatment of MAPK-driven tumors. Clin Cancer Res. 2021 Apr 1;27(7):2061-2073. PMID: 33355204
Park S, Kim T, Cho S, et al. Combined blockade of polo-like kinase and pan-RAF is effective against NRAS-mutant non-small cell lung cancer cells. Cancer Lett. 2020 Dec 28;495:135-144. PMID: 32979462
β-lactam; penicillin binding protein inhibitor...
Peptide fragment of HER2/neu/erbB2 receptor.
Mycotoxin produced by species of Aspergillus; D...
Endogenous amino acid sugar involved in cartila...
Ca2+-sensing receptor antagonist.
Neuropeptide hormone found in insects, involved...
Non-alkaloid lignan found in Podophyllum,deriva...
Found in Taxus, starting material for synthesis...
Cortisol derivative; glucocorticoid agonist.
Nicotinic acid derivative; InhA inhibitor.
Abl (T315I) inhibitor.
CDK inhibitor.
5-Nitroimidazole derivative; genotoxic.
Peptide, urocortin II analog; CRFR2 agonist.
Synthesis impurity
Synthetic derivative of glycyrrhizin; connexin ...
α-glucosidase inhibitor, potential GLP-1 agoni...
ITC, erucin analog.
NSAID; COX-1/2 inhibitor.